Eurogentec welcomed Minister Borsus and AWEX representatives to visit our new facilities and learn more about our COVID-19 current activity and future development plan.
Lieven Janssens (CEO) introduced our activities, technologies and future development plan.
We also had an interesting discussion about how we help the life science and pharma community to get rid of the SARS-CoV-2 virus.
Beside producing a lot of qPCR reagents for COVID-19 testing, we participate actively in the development and manufacturing of new vaccine generation for clinical trials and commercialization: DNA vaccines and RNA vaccines.
The participants visited our new GMP production facilities equipped with a 2200 L fermentor for large scale biomanufacturing of therapeutic molecules. It was a good opportunity to let them know how much we appreciate the collaborative support of the Walloon region and AWEX.